SLN – silence therapeutics plc - american depository share (US:NASDAQ)

News

Silence Therapeutics: Divesiran Targets High-Burden PV [Seeking Alpha]
Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Need To Know: Analysts Just Made A Substantial Cut To Their Silence Therapeutics plc (NASDAQ:SLN) Estimates [Yahoo! Finance]
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com